1. Li, Chao, Ma, Qiu-Ying, Liu, Xue-Qi, Yao, Ri-Sheng, Meng, Xiao-Ming. 2023. Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis. In Molecular therapy : the journal of the American Society of Gene Therapy, 31, 2734-2754. doi:10.1016/j.ymthe.2023.06.016. https://pubmed.ncbi.nlm.nih.gov/37415332/
2. Moreno, Paola, Mantey, Samuel A, Lee, Suk H, Moody, Terry W, Jensen, Robert T. 2018. A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3. In Peptides, 101, 213-226. doi:10.1016/j.peptides.2018.01.016. https://pubmed.ncbi.nlm.nih.gov/29410320/
3. Mansi, Rosalba, Fleischmann, Achim, Mäcke, Helmut R, Reubi, Jean C. 2013. Targeting GRPR in urological cancers--from basic research to clinical application. In Nature reviews. Urology, 10, 235-44. doi:10.1038/nrurol.2013.42. https://pubmed.ncbi.nlm.nih.gov/23507930/
4. Li, Heli, Wang, Xinyuan, Hu, Cong, Luo, Xiaoping, Hao, Yan. 2024. IL-6 Enhances the Activation of PI3K-AKT/mTOR-GSK-3β by Upregulating GRPR in Hippocampal Neurons of Autistic Mice. In Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 19, 12. doi:10.1007/s11481-024-10111-3. https://pubmed.ncbi.nlm.nih.gov/38536552/
5. Begum, Anjuman Ara, Wan, Yu, Toth, Istvan, Moyle, Peter M. 2017. Bombesin/oligoarginine fusion peptides for gastrin releasing peptide receptor (GRPR) targeted gene delivery. In Bioorganic & medicinal chemistry, 26, 516-526. doi:10.1016/j.bmc.2017.12.013. https://pubmed.ncbi.nlm.nih.gov/29269254/
智鼠故事 
